ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05145	Toxoplasmosis	3/10	126/7206	0.000572644814022
ko05134	Legionellosis	2/10	74/7206	0.00443886609396
ko04512	ECM-receptor interaction	2/10	79/7206	0.00504463506557
ko05133	Pertussis	2/10	87/7206	0.00608906450597
ko05222	Small cell lung cancer	2/10	89/7206	0.00636446240608
ko05146	Amoebiasis	2/10	99/7206	0.00782584134043
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1/10	15/7206	0.0206348465182
ko05164	Influenza A	2/10	167/7206	0.0212616616555
ko05200	Pathways in cancer	3/10	492/7206	0.0264475069586
ko00515	Mannose type O-glycan biosynthesis	1/10	25/7206	0.0341776765161
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1/10	28/7206	0.0382075280646
ko00514	Other types of O-glycan biosynthesis	1/10	30/7206	0.0408856819385
ko04510	Focal adhesion	2/10	240/7206	0.0416740984301
ko04392	Hippo signaling pathway -multiple species	1/10	31/7206	0.0422222403527
ko00052	Galactose metabolism	1/10	33/7206	0.0448903294934